Results 11 to 20 of about 33,264 (215)

CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its pleiotropic effect (influence on endothelial function and antiatherogenic action) is presented.
M. V. Leonova
doaj   +1 more source

Modern views on amlodipine and new S-amlodipine medications

open access: yesКардиоваскулярная терапия и профилактика, 2011
The review presents the latest evidence on the calcium antagonist amlodipine, summarizing its mechanisms of action, its pleiotropic, endothelial function-related effects, and its anti-atherogenic activity.
M. V. Leonova
doaj   +1 more source

Amlodipine gynaecomastia

open access: yesThe Breast, 2001
We report only the second published confirmed case of gynaecomastia caused by amlodipine (a dihydropyridine calcium channel blocker). Gynaecomastia developed in a 70-year-old male within 3 months of starting amlodipine, and symptoms resolved within 3 weeks of drug withdrawal suggesting a strong relationship between amlodipine and gynaecomastia in this ...
P G, Cornes, A C, Hole
openaire   +2 more sources

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and ...
M. A. Maksimova   +2 more
doaj   +3 more sources

Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity. [PDF]

open access: yesDrug Dev Res
ABSTRACT Hexahydroquinoline (HHQ) is a widely recognized scaffold that has garnered considerable attention owing to its diverse pharmacological properties. The structure of HHQ includes a 1,4‐dihydropyridine (DHP) ring, which serves as the pharmacophore for the predominant class of drugs known as calcium channel blockers.
Koçak Aslan E   +13 more
europepmc   +2 more sources

Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study [PDF]

open access: yesEpidemiology and Health
OBJECTIVES This study investigated the safety of azilsartan and amlodipine combination therapy versus other angiotensin receptor blockers (ARBs) and amlodipine in patients with hypertension.
Hyesung Lee   +9 more
doaj   +1 more source

The Effects of Amlodipine on the Biochemical and Histopathological Changes in the Rabbit Ileum Subjected to Ischemia-Reperfusion

open access: yesEurasian Journal of Medicine, 2019
Objective: The aim of this study was to determine the potential, protective effects of amlodipine in an experimental, ischemia-reperfusion (I/R) model in the rabbit small intestine.
A. Kagan Coskun   +9 more
doaj   +1 more source

COMPARATIVE STUDY OF EFFICIENCY AND SAFETY OF THE NEW DRUG OF AMLODOPINE – S-AMLODOPINE IN PATIENTS WITH ARTERIAL HYPERTENSION OF I-II DEGREE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate efficacy and safety of a new drug of amlodipine – S-amlodipine (Azomex, Emcur, India) compared to original drug of racemic amlodipine (Norvasc, Pfizer, USA) in patients with arterial hypertension (HT) of I-II grade.Material and methods ...
M. A. Maksimova   +5 more
doaj   +1 more source

Impact of Cumin and Green Tea on Amlodipine Pharmacodynamics and Pharmacokinetics in Hypertensive Rats

open access: yesSeparations, 2023
The main purpose of the current research was to determine the impact of cumin and green tea on the pharmacodynamics and pharmacokinetics of amlodipine in hypertensive rats. Wistar rats were given 40 mg/kg of L-NAME orally every day for two weeks in order
Ibrahim Abdelsalam Abdelrahman   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy